SE392900B - Forfarande for framstellning av ftalazinderivat - Google Patents

Forfarande for framstellning av ftalazinderivat

Info

Publication number
SE392900B
SE392900B SE7111606A SE1160671A SE392900B SE 392900 B SE392900 B SE 392900B SE 7111606 A SE7111606 A SE 7111606A SE 1160671 A SE1160671 A SE 1160671A SE 392900 B SE392900 B SE 392900B
Authority
SE
Sweden
Prior art keywords
procedure
preparation
phthalazine derivatives
phthalazine
derivatives
Prior art date
Application number
SE7111606A
Other languages
English (en)
Inventor
K Ueno
S Miyazaki
A Akashi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of SE392900B publication Critical patent/SE392900B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/34Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/30Phthalazines
    • C07D237/32Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7111606A 1970-09-14 1971-09-13 Forfarande for framstellning av ftalazinderivat SE392900B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8065970 1970-09-14

Publications (1)

Publication Number Publication Date
SE392900B true SE392900B (sv) 1977-04-25

Family

ID=13724472

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7111606A SE392900B (sv) 1970-09-14 1971-09-13 Forfarande for framstellning av ftalazinderivat

Country Status (12)

Country Link
US (1) US3840539A (sv)
AR (1) AR195956A1 (sv)
BE (1) BE772514A (sv)
CA (1) CA968799A (sv)
CH (1) CH537389A (sv)
DE (1) DE2145359B2 (sv)
ES (1) ES395391A1 (sv)
FR (1) FR2106516B1 (sv)
GB (1) GB1342760A (sv)
NL (1) NL145229B (sv)
SE (1) SE392900B (sv)
ZA (1) ZA716009B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061636A (en) * 1976-02-12 1977-12-06 Warner-Lambert Company Naphthalenone phthalazinylhydrazones
US6825196B2 (en) * 2002-03-05 2004-11-30 Barbeau Pharma, Inc. Stable pharmaceutical compositions
US6821974B2 (en) * 2002-03-05 2004-11-23 Barbeau Pharma, Inc Stable pharmaceutical compositions
WO2007097951A2 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
EP2024337A4 (en) * 2006-05-16 2011-09-14 Nitromed Inc SOLID DOSAGE FORMULATIONS OF HYDRALAZIN COMPOUNDS

Also Published As

Publication number Publication date
FR2106516A1 (sv) 1972-05-05
NL7112603A (sv) 1972-03-16
GB1342760A (en) 1974-01-03
ZA716009B (en) 1972-05-31
NL145229B (nl) 1975-03-17
FR2106516B1 (sv) 1974-10-18
CA968799A (en) 1975-06-03
DE2145359B2 (de) 1976-06-24
ES395391A1 (es) 1973-12-16
DE2145359A1 (de) 1972-03-16
BE772514A (fr) 1972-01-17
US3840539A (en) 1974-10-08
CH537389A (fr) 1973-05-31
AR195956A1 (es) 1973-11-23

Similar Documents

Publication Publication Date Title
SE414497B (sv) Forfarande for framstellning av p-karbonyloxim-fenoxialkyl-karboxamider
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE394678B (sv) Analogiforfarande for framstellning av pyridokinolinderivat
SE390306B (sv) Forfarande for framstellning av piperidinderivat
NO138883C (no) Fremgangsmaate for fremstilling av oksiranforbindelser
SE388422B (sv) Forfarande for reduktion av theabin
SE399701B (sv) Forfarande for framstellning av hydroxyalkyldiamin
SE384680B (sv) Forfarande for framstellning av bis-kromon-derivat
SE394436B (sv) Forfarande for framstellning av 7-halogen-linkomyciner
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE392615B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE385011B (sv) Forfarande for framstellning av alfa-linkosaminider
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
SE395897B (sv) Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror
SE395699B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
SE408418B (sv) Forfarande for framstellning av 5-fluor-pyrimidiner
SE392900B (sv) Forfarande for framstellning av ftalazinderivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE380528B (sv) Forfarande for framstellning av 2-klor-7-hydroxi-11-piperazinyldibensoxazepmderivat
SE380795B (sv) Forfarande for framstellning av tiokarbamider
SE411759B (sv) Forfarande for framstellning av erytromycyliminforeningar
SE382051B (sv) Forfarande for framstellning av 3-sulfonamid-4-hydroxifenyl-2-piperidylkarbinoler
SE382046B (sv) Forfarande for framstellning av 1-aryloxi-2-propanol